1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
ABCL - 313
waveLINE-011: Zilovertamab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) vs Polatuzumab Vedotin Plus R-CHP as First-Line Therapy in Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
Poster Presenter
Authors
Part of Topic
Aggressive B-Cell Lymphoma (ABCL)
File name: Topp_WL011 TiP Encore_SOHO_2026_Final Poster
Poster Number: ABCL-313
Poster Title: waveLINE-011: Zilovertamab Vedotin Plus Rituximab, Cyclophosphamide,Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP
as First-Line Therapy in Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma